Search - tctmd.com

Displaying 601 - 620 of 9030

Sort: Relevancy | Date

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

Podcast Heart Valve Matters

Challenges of Long-Term Follow-Up with Sreek Vemulapalli and Roseann White

February 14, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

Presentation THT 2025

Clinical Trial Options

Presenter: Navin Kapur

February 13, 2025

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

AI Echo's Potential to Transform HF Management

Presenter: Carolyn Lam

February 12, 2025

Presentation THT 2025

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Presenter: Jonathan Cunningham

February 12, 2025

Presentation THT 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presenter: Akhil Narang

February 12, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT 2025

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Presenter: Ralph von Bardeleben

February 12, 2025

Presentation THT 2025

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Presenter: Joao Cavalcante

February 12, 2025

Advertisement

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Challenges of Long-Term Follow-Up with Sreek Vemulapalli and Roseann White

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Clinical Trial Options

This Strategy Has Saved the Startup Medical Device Sector

Down-Stream Challenges: Reimbursement and Guidelines

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

AI Echo's Potential to Transform HF Management

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content